DNA vaccines targeting the encoded antigens to dendritic cells induce potent antitumor immunity in mice

Sortase-mediated modification of αDEC205 affords optimization of antigen presentation and immunization against a set of viral epitopes

(2013) Lee Kim Swee et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Trial watch

(2012) Lorenzo Galluzzi et al.   OncoImmunology

Anti-PD-1 synergizes with cyclophosphamide to induce potent anti-tumor vaccine effects through novel mechanisms

(2011) Mikayel Mkrtichyan et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Targeted Delivery of Tumor Antigens to Activated Dendritic Cells via CD11c Molecules Induces Potent Antitumor Immunity in Mice

(2009) H. Wei et al.   CLINICAL CANCER RESEARCH

Administration of Cyclophosphamide Changes the Immune Profile of Tumor-bearing Mice

(2009) Pu Liu et al.   JOURNAL OF IMMUNOTHERAPY

Cancer Immunotherapy Using In vitro Genetically Modified Targeted Dendritic Cells

(2008) H. Wei et al.   CANCER RESEARCH

DNA Vaccines Targeting Tumor Antigens to B7 Molecules on Antigen-Presenting Cells Induce Protective Antitumor Immunity and Delay Onset of HER-2/Neu-Driven Mammary Carcinoma

(2008) A. Sloots et al.   CLINICAL CANCER RESEARCH

The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells

(2008) Godwin Nchinda et al.   JOURNAL OF CLINICAL INVESTIGATION